A Swiss CBD company claims to have become the first cannabidiol firm to use liposomes to deliver the substance into users’ bodies.

Cibdol, based in Liestal, near Basel, says its range of products, launched in December, will enter the user’s system as much as four times quicker than traditional oils and capsules.

Liposomes, which have most notably been used for some cancer treatments, are microscopic pockets made from the same material as cell membranes which can be filled with medicines, drugs, and vitamins.

Because they are made from a substance extensively found in cells – phospholipids – they penetrate directly into tissue and cell walls, and can pass directly into a patient’s bloodstream.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us